Cost-effectiveness of a non-invasive prenatal test for genetic disorders
Part of Genetic & congenital clinical trials.
This study is testing a non-invasive prenatal blood test (NIPD) that can check for certain serious genetic disorders in your baby, instead of using more invasive methods like amniocentesis. If you are at risk of passing on a severe genetic condition, this test may help you get answers safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You and your partner are both over 18 and your pregnancy is at least 7 weeks along.
- Your doctor has recommended a prenatal test (like amniocentesis or a special blood test) for a serious genetic condition, and a special prenatal center (CPDPN) has approved it.
- The condition's gene can be found with a specific genetic test (called the Agilent V8 exome capture kit).
- You (the pregnant woman) do NOT carry the disease gene yourself.
- You and your partner have French social security and both agree to join the study.
- Neither you nor your partner is in prison, under guardianship, or under curatorship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a safer blood test to check for certain genetic disorders during pregnancy, instead of an invasive procedure like amniocentesis. It's for pregnant women who are at risk of passing on a known genetic condition.
This study tests whether sequencing the genes of the fetus alongside the parents' genes can help find the cause of certain ultrasound abnormalities during pregnancy. If you are pregnant and your doctor has suggested genetic testing due to unusual findings on ultrasound, this study may help provide a more precise diagnosis.
This study looks at a new blood test to screen for single-gene disorders (conditions caused by changes in one gene) during pregnancy. It may help if you or your baby's father carry a genetic disorder, or if an ultrasound shows signs of a possible genetic condition.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
Hear when a new Genetic Diseases, Inborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.